Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast Cancer

Breast cancer is a heterogeneous disease with differences in its clinical, molecular and biological features. Traditionally, immunohistochemical markers together with clinicopathologic parameters are used to classify breast cancer and to predict disease outcome. Triple-negative breast cancer (TNBC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Manica, Graciele C. M., Ribeiro, Caroline F., Oliveira, Marco A. S. de, Pereira, Isabela T., Chequin, Andressa, Ramos, Edneia A. S., Klassen, Liliane M. B., Sebastião, Ana Paula M., Alvarenga, Larissa M., Zanata, Silvio M., Noronha, Lucia De, Rabinovich, Iris, Costa, Fabricio F., Souza, Emanuel M., Klassen, Giseli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353751/
https://www.ncbi.nlm.nih.gov/pubmed/28294120
http://dx.doi.org/10.1038/srep44414

Ejemplares similares

Ejemplares similares